Innovation Pharmaceuticals Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, Pinnacle Accountancy Group of Utah, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | +50.00% | -28.57% | -38.78% |
Feb. 01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-38.78% | 1.59M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- IPIX Stock
- News Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt